Already a member? Sign in
Mycophenolate is an immunosuppressant agent indicated for the prevention organ rejection in patients receiving allogeneic renal, cardiac or hepatic transplants. Mycophenolate should be used concomitantly with cyclosporine and corticosteroids.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Prevent organ rejection | 426 | 24 |
|
|
|
|
|
| Transplant rejection prevention | 265 | 67 |
|
|
|
|
|
| MS (Multiple Sclerosis) | 58 | 13 |
|
|
|
|
|
| Transplant rejection | 28 | 7 |
|
|
|
|
|
| Kidney Transplant | 26 | 3 |
|
||||
| Neuromyelitis Optica | 26 | 12 |
|
|
|
|
See all 870 patients currently taking Mycophenolate
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Mycophenolate
| Diarrhea | 10 | |
|---|---|---|
| Hair loss (alopecia) | 7 | |
| Tremor in hands | 5 | |
| Fatigue | 5 | |
| Diarrhea chronic | 4 | |
| Nausea | 3 | |
| See all 79 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Mycophenolate. See all 40 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Side effects too severe | 45 | ||
| Doctor's advice | 42 | ||
| Other | 35 | ||
| Did not seem to work | 14 | ||
| Course of treatment ended | 9 | ||
| Personal research | 3 | ||
| Change in health plan coverage | 3 | ||
| Expense | 1 | ||
| Not indicated | 1 |
Adherence
Taking treatment as prescribed
Adherence of Mycophenolate
Always |
121 | 87% |
|
|---|---|---|---|
Usually |
13 | 9% |
|
Sometimes |
2 | 1% |
|
Never |
3 | 2% |
|
Burden
Difficulty being on treatment
Burden of Mycophenolate
Very |
7 | 5% |
|
|---|---|---|---|
Somewhat |
11 | 8% |
|
A little |
31 | 22% |
|
Not at all |
90 | 65% |
|
Cost
Paid out of pocket
Cost of Mycophenolate
$200+ |
9 | 10% |
|
|---|---|---|---|
$100-199 |
8 | 9% |
|
$50-99 |
12 | 13% |
|
$25-49 |
11 | 12% |
|
< $25 |
49 | 54% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on February 11, 2012.